C. difficile vaccine (previously studied formulation).

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Drug Information

Target Indication

Clostridoides Difficile Associated Disease

Clinical Trial

Last updated: 2/7/2026

Developer

PFE

PFIZER

Related Pipeline

Bronchitis, Chronic

Major Depressive Disorder

Diabetes Mellitus

Menopause

Vasomotor Symptoms